Personalized genetic diagnosis of hereditary neurological diseases

Personalized medicine is methods for preventing of pathological conditions, diagnosing and treating based on the individual characteristics of the patient. Prevention of hereditary and congenital pathologies is the main goal of institutions and departments of medical genetic services. The need for genetic testing of children with congenital and hereditary diseases is 25,3%. The diversity of hereditary diseases was established based on the results of the study and analysis. The capabilities of the genetic laboratory are shown and the use of methods of molecular genetic diagnosis in children is scientifically justified. It has been shown that confirmation of more than 50% of genetic diseases by molecular genetic methods makes possibility to implement genotype-phenotype correlations and plan further medical observation of the child. The clinical effectiveness of whole exome sequencing to establish molecular diagnosis of hereditary and congenital pathologies was 73,3%. As part of the implementation of the strategy for the development of molecular genetic diagnostics, the spectrum of identified nucleotide sequence variants in genes responsible for hereditary and congenital pathologies was analyzed. Based on the obtained data and identified options, recommendations were given to doctors on the effectiveness of treatment, and individual rehabilitation programs were developed, in some cases excluding surgical correction of the defect in patients with movement disorders.

1. Pal’tsev M.A. Medicine of the Future. Personalized Medicine: Experience of the Past, Realities of Tomorrow. Moscow: Russian Academy of Sciences, 2020; 152 p. (in Russ.)

2. Kobrinsky B.A. Personalized medicine: genome, electronic health care and intelligent systems. Part 1. Genomics and monitoring of clinical data. Russian Vestn Perinatol i Pediatr 2017; 62(5): 16–20. (in Russ.)

3. Government of the Russian Federation. Order of December 28, 2012 N 2580-r “On approval of the Strategy for the Development of Medical Science in the Russian Federation for the period up to 2025” (in Russ.) https://www.consultant.ru/document/cons_doc_LAW_140249 / Ссылка активна на 01.20.2025

4. On the activities of medical genetic consultations and centers in the subjects of the Russian Federation. Materials of the meeting of the Council on Regional Healthcare under the Federation Council of the Federal Assembly of the Russian Federation (Federation Council, September 25, 2020). (in Russ.) URL: http://council.gov.ru/media/files/oPnf3ZdrMbAOBrNTPEhzA6hL1cNtwgpr.pdf / Ссылка активна на 01.20.2025

5. World Health Organization (WHO). https://www.who.int/genomics/public/geneticdiseases / Ссылка активна на 20.01.2025

6. Demikova N.S., Kobrinsky B.A., Lapina A.S. Frequency and structure of congenital malformations according to monitoring data. Medical Genetics 2005; 4(4): 115. (in Russ.)

7. Blinnikova O.E. Semiotics of hereditary diseases: textbook. Moscow: Almanac «Healing», 2000; 113 p. (in Russ.)

8. Kozlova S.I., Demikova N.S. Hereditary syndromes and medical-genetic counseling: textbook. Moscow: KMK, Author’s Academy, 2007; 448 p. (in Russ.)

9. Mutovin G.R., Zhilina S.S., Zavadenko N.N., Belenikin M.S. Signs and diseases with traditional and non-traditional inheritance: teaching aid. Moscow: Special Publishing House of Medical Books, 2015; 104 p. (in Russ.)

10. Wright C.F., FitzPatrick D.R., Firth H.V. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet 2018; 19(5): 253–268. DOI: 10.1038/nrg.2017.116

11. Parenti I., Rabaneda L.G., Schoen H., Novarino G. Neurodevelopmental Disorders: From Genetics to Functional Pathways. Trends Neurosci 2020; 43(8): 608–621. DOI: 10.1016/j.tins.2020.05.004

12. Online Mendelian Inheritance in Man — OMIM database. (in Russ.) https://www.omim.org/phenotypicSeries/PS308350?sort=phenotype / Ссылка активна на 12.12.2023).

13. Perucca P., Bahlo M., Berkovic S.F. The Genetics of Epilepsy. Annu Rev Genomics Hum Genet 2020; 21: 205–230. DOI: 10.1146/annurev-genom-120219–074937

14. Ding J., Li X., Tian H, Wang L., Guo B., Wang Y., et al. SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis. Front Neurol 2021; 12: 743726. DOI: 10.3389/fneur.2021.743726

15. Koch H., Weber Y.G. The glucose transporter type 1 (Glut1) syndromes. Epilepsy Behav 2019; 91: 90–93. DOI: 10.1016/j.yebeh.2018.06.010

16. Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–424. DOI: 10.1038/gim.2015.30

17. South S.T., Lee C., Lamb A.N., Higgins A.W., Kearney H.M.; Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med 2013; 15(11): 901–909. DOI: 10.1038/gim.2013.129

18. Ryzhkova O.P., Kardymon O.L., Prokhorchuk E.B., Konovalov F.A., Maslennikov A.B., Stepanov V.A., et al. Guide to Interpreting Data Obtained by Massively Parallel Sequencing (MPS) Methods. Medicinskaya genetika 2017; 16(7): 4–17. (in Russ.)

19. Indications for whole-genome sequencing in patients with suspected hereditary rare diseases: A tutorial. Demikova N.S., Baranova E.E. Federal State Budgetary Educational Institution of Higher Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Health of the Russian Federation. M.: Federal State Budgetary Educational Institution of Higher Professional Education RMANPO of the Ministry of Health of the Russian Federation, 2022; 102 p. (in Russ.)

20. Wirrell E., Tinuper P., Perucca E., Moshé S.L. Introduction to the epilepsy syndrome papers. Epilepsia 2022; 63(6): 1330–1332. DOI: 10.1111/epi.17262

21. Kalser J., Cross J.H. The epileptic encephalopathy jungle — from Dr West to the concepts of aetiology-related and developmental encephalopathies. Curr Opin Neurol 2018; 31(2): 216–222. DOI: 10.1097/WCO.0000000000000535

22. Guerrini R., Conti V., Mantegazza M., Balestrini S., Galanopoulou A.S., Benfenati F. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev 2023; 103(1): 433–513. DOI: 10.1152/physrev.00063.2021

23. Scheffer I.E., Liao J. Deciphering the concepts behind «Epileptic encephalopathy» and «Developmental and epileptic encephalopathy». Eur J Paediatr Neurol 2020; 24: 11–14. DOI: 10.1016/j.ejpn.2019.12.023

24. Scheffer I.E., Berkovic S., Capovilla G., Connolly M.B., French J., Guilhoto L., et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58(4): 512–521. DOI: 10.1111/epi.13709

25. Vetri L., Calì F., Saccone S., Vinci M., Chiavetta N.V., Carotenuto M., et al. Whole Exome Sequencing as a First-Line Molecular Genetic Test in Developmental and Epileptic Encephalopathies. Int J Mol Sci 2024; 25(2): 1146. DOI: 10.3390/ijms25021146

26. Kozhanova T.V., Zhilina S.S., Meshcheryakova T.I., Abramov A.A. Personalized genetic diagnostics of hereditary and congenital pathology in multidisciplinary pediatric clinic No. 42, Moscow: Department of Health of the Ministry of Health, 2024; 36 p. (in Russ.)